NetworkNewsBreaks Archive - Page 32 of 2246

WednesdayJun 17, 2026 11:24 am

NetworkNewsBreaks – IBN.Ai Celebrates 20 Years of Growth, Expands AI-Powered Communications Platform

IBN.Ai, the corporate communications and digital engagement platform developed by IBN, is marking the company's 20th anniversary by highlighting two decades of growth, innovation and service to the investment community while advancing a new phase centered on artificial intelligence. Over the past 20 years, IBN has evolved into a multifaceted communications organization supported by a Dynamic Brand Portfolio of more than 75 investor-facing brands, relationships with more than 5,000 syndication partners and a social media network reaching millions of followers and subscribers. As it enters its next chapter, IBN is expanding its AI-focused ecosystem through brands including IBN.Ai, AINewsWire, InvestorBrand, Investor Intelligence Artificial…

WednesdayJun 17, 2026 11:16 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Expands Ukraine Strategy with CFC Defence Engagement

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced it has engaged Ukraine-based CFC Defence to lead the company's market-entry and strategic-engagement program across Ukraine's defense ecosystem. The move advances SPARC AI's efforts to deploy its Overwatch GPS-denied navigation and targeting platform, following a series of recently announced milestones including agreements with Ukrainian drone manufacturers, the appointment of a local sales agent, expansion of business development and engineering teams, legal support arrangements and plans to establish a physical office in Ukraine. Under the agreement, CFC Defence will help identify and engage key Ukrainian military, government…

WednesdayJun 17, 2026 10:32 am

NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Completes AI and Quantum Computing Pilot for PNKP Inhibitor Program

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced the successful completion of a pilot project with Kuano Ltd. that supports advancement of the company's PNKP Inhibitor Technology (ONC010) through AI-enabled and quantum-based computational analysis. Kuano delivered molecular modeling and computational findings that strengthened Onco's understanding of how its PNKP inhibitor and related analogs may interact with the target, producing a refined structural hypothesis for PNKP inhibition and establishing a framework for structure-based optimization and future evaluation. The project also applied quantum-based computational methods to assess PNKP structural behavior and develop human PNKP structural models for follow-on…

WednesdayJun 17, 2026 10:10 am

NetworkNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Receives Additional DefendAir Order From Tier-1 Defense Customer

ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional order for its DefendAir Net Pod system from a second business unit within a Tier-1 Israeli-based global defense company. The order is intended to support integration of the DefendAir Net Pod into the customer's autonomous ground-based Counter-UAS platform and includes dedicated engineering integration services from ParaZero. The company said its DefendAir Net Pod provides a non-explosive, net-based drone interception capability designed for environments where precision, mobility and reduced collateral damage are critical. According to ParaZero, the order reflects growing demand for autonomous Counter-UAS platforms and supports its broader strategy of…

WednesdayJun 17, 2026 9:40 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Robotics Deployment at SAPU Bio Sterile Manufacturing Facility

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, announced the advancement of Phase 2 objectives under its joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the deployment of PUR-E, an autonomous clean room support robot, within SAPU Bio's OEB-5 sterile injectable cGMP facility. The deployment expands the initiative beyond Phase 1 materials logistics operations and into sterile manufacturing and clean room environments, where TechForce and Oncotelic are evaluating robotics, automation and AI-driven technologies to support regulated pharmaceutical workflows. PUR-E joins TechForce's LIM-E autonomous GMP support robot at the SAPU Bio facility, where the systems are being used to assess opportunities in sterile manufacturing operations, electronic batch record processes…

WednesdayJun 17, 2026 9:10 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Positioned to Benefit From Growing Demand for AI Infrastructure Automation

Nightfood Holdings (OTCQB: NGTF) operating through TechForce Robotics, is featured in a new AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is increasing demand for advanced automation, robotics and precision manufacturing solutions. The report highlights TechForce's recent partnership with Jiun Jiang ("JJ Enterprise") to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics, positioning the company alongside major AI ecosystem participants including Super Micro Computer Inc. (NASDAQ: SMCI), Palantir Technologies Inc. (NASDAQ: PLTR), Applied Materials Inc. (NASDAQ: AMAT) and KLA Corporation (NASDAQ: KLAC). The editorial notes that growing investment in AI data centers, advanced semiconductor packaging and…

WednesdayJun 17, 2026 9:00 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances AI-Powered GMP Manufacturing Platform

Oncotelic Therapeutics (OTCQB: OTLC) announced the completion of key Phase 2 objectives in its manufacturing automation initiative with TechForce Robotics, advancing commercialization of an AI-powered good manufacturing practices manufacturing services platform at SAPU Bio, the company's 45%-owned sterile injectable cGMP manufacturing joint venture. The Phase 2 deployment expands the capabilities of Oncotelic's proprietary PDAOAI(TM) platform across sterile manufacturing operations, electronic batch records, GMP workflow execution, cleanroom monitoring and autonomous materials movement. The company said the integrated platform combines PDAOAI(TM) with TechForce's autonomous robotic systems to support intelligent pharmaceutical manufacturing and create potential opportunities in software licensing, automation deployment, manufacturing partnerships…

TuesdayJun 16, 2026 2:15 pm

NetworkNewsBreaks – Space Exploration Technologies Corp. (NASDAQ: SPCX) (SpaceX) Surpasses Amazon in Market Value as Post-IPO Rally Accelerates

SpaceX (NASDAQ: SPCX) briefly surpassed Amazon.com in market capitalization on June 16 as investors continued piling into shares following the company's record-setting initial public offering, according to a Reuters report. Reuters reported that shares of Elon Musk's rocket, satellite and artificial intelligence company climbed as much as 10%, pushing its valuation above $2.7 trillion and, at one point, ahead of both Amazon and Microsoft among the world's most valuable companies. The surge was fueled in part by the launch of options trading in SpaceX shares and growing investor enthusiasm surrounding the company's expanding presence in space technology, communications and artificial intelligence. Reuters noted that analysts expect additional buying pressure as SpaceX is positioned…

TuesdayJun 16, 2026 1:57 pm

NetworkNewsBreaks – Humacyte Inc. (NASDAQ: HUMA) Prices $50 Million Public Offering

Humacyte (NASDAQ: HUMA) announced the pricing of an underwritten public offering of 47.6 million shares of common stock at $1.05 per share, with expected gross proceeds of approximately $50 million before underwriting discounts, commissions and offering expenses. The company also granted underwriters a 30-day option to purchase up to an additional 7.1 million shares at the public offering price. The offering is expected to close on or about June 12, 2026, subject to customary closing conditions. Humacyte said it intends to use the net proceeds to support commercialization of Symvess(R), advance a planned Biologics License Application supplement filing for a hemodialysis indication, fund development of pipeline candidates and provide working capital…

TuesdayJun 16, 2026 1:45 pm

NetworkNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) Builds Gateway to High-Growth Opportunities in Space and Aerospace

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising. Structured as a publicly traded investment issuer, Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) provides investors with exposure to private space and aerospace companies that would otherwise remain inaccessible to most retail participants. “In a TechMediaWire podcast interview, Chief Executive Officer Etienne Moshevich described Planet’s evolution over the past two and a half years, explaining how the company transformed from approximately $5 million in cash and assets into a platform now holding roughly $20 million while shifting toward a dedicated space-focused investment strategy,” reads…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks